in Newswire Published on May 9, 2022

SD Biosensor Facing Class Action After Voluntary Recall of Unapproved Standard Q At-Home COVID Tests

Cenci v. SD Biosensor USA, Inc.

Filed: May 6, 2022 § 1:22-cv-02613

A class action alleges the maker of the SDB Standard Q at-home covid test has failed to disclose that the tests are not authorized, cleared or approved for distribution in U.S. by the FDA.


New York

Case Spotlight

Camp Lejeune Newsletter

Stay Current

Sign Up For
Our Newsletter

New cases and investigations, settlement deadlines, and news straight to your inbox.

This browser does not support PDFs. Please download the PDF to view it: Download PDF.

Last Updated on May 9, 2022 — 4:38 PM

Corrado Rizzi

Corrado Rizzi is the Managing Editor and a writer for

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.